1887
  1. Home
  2. Eurosurveillance
  3. Volume 29, Issue 2, 11/Jan/2024
  4. Article
Research Open Access
Like 0
Download

Abstract

Background

In Sweden, information on seroprevalence of tick-borne encephalitis virus (TBEV) in the population, including vaccination coverage and infection, is scattered. This is largely due to the absence of a national tick-borne encephalitis (TBE) vaccination registry, scarcity of previous serological studies and use of serological methods not distinguishing between antibodies induced by vaccination and infection. Furthermore, the number of notified TBE cases in Sweden has continued to increase in recent years despite increased vaccination.

Aim

The aim was to estimate the TBEV seroprevalence in Sweden.

Methods

In 2018 and 2019, 2,700 serum samples from blood donors in nine Swedish regions were analysed using a serological method that can distinguish antibodies induced by vaccination from antibodies elicited by infection. The regions were chosen to reflect differences in notified TBE incidence.

Results

The overall seroprevalence varied from 9.7% (95% confidence interval (CI): 6.6–13.6%) to 64.0% (95% CI: 58.3–69.4%) between regions. The proportion of vaccinated individuals ranged from 8.7% (95% CI: 5.8–12.6) to 57.0% (95% CI: 51.2–62.6) and of infected from 1.0% (95% CI: 0.2–3.0) to 7.0% (95% CI: 4.5–10.7). Thus, more than 160,000 and 1,600,000 individuals could have been infected by TBEV and vaccinated against TBE, respectively. The mean manifestation index was 3.1%.

Conclusion

A difference was observed between low- and high-incidence TBE regions, on the overall TBEV seroprevalence and when separated into vaccinated and infected individuals. The estimated incidence and manifestation index argue that a large proportion of TBEV infections are not diagnosed.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2024.29.2.2300221
2024-01-11
2024-04-27
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2024.29.2.2300221
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/29/2/eurosurv-29-2-7.html?itemId=/content/10.2807/1560-7917.ES.2024.29.2.2300221&mimeType=html&fmt=ahah

References

  1. Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet. 2008;371(9627):1861-71.  https://doi.org/10.1016/S0140-6736(08)60800-4  PMID: 18514730 
  2. Im JH, Baek JH, Durey A, Kwon HY, Chung MH, Lee JS. Geographic distribution of tick-borne encephalitis virus complex. J Vector Borne Dis. 2020;57(1):14-22.  https://doi.org/10.4103/0972-9062.308794  PMID: 33818450 
  3. Ruzek D, Avšič Županc T, Borde J, Chrdle A, Eyer L, Karganova G, et al. Tick-borne encephalitis in Europe and Russia: review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Res. 2019;164:23-51.  https://doi.org/10.1016/j.antiviral.2019.01.014  PMID: 30710567 
  4. Jääskeläinen AE, Tonteri E, Sironen T, Pakarinen L, Vaheri A, Vapalahti O. European subtype tick-borne encephalitis virus in Ixodes persulcatus ticks. Emerg Infect Dis. 2011;17(2):323-5.  https://doi.org/10.3201/eid1702.101487  PMID: 21291624 
  5. Ličková M, Fumačová Havlíková S, Sláviková M, Klempa B. Alimentary infections by tick-borne encephalitis virus. Viruses. 2021;14(1):56.  https://doi.org/10.3390/v14010056  PMID: 35062261 
  6. Martello E, Gillingham EL, Phalkey R, Vardavas C, Nikitara K, Bakonyi T, et al. Systematic review on the non-vectorial transmission of Tick-borne encephalitis virus (TBEv). Ticks Tick Borne Dis. 2022;13(6):102028.  https://doi.org/10.1016/j.ttbdis.2022.102028  PMID: 36030646 
  7. Gonzalez G, Bournez L, Moraes RA, Marine D, Galon C, Vorimore F, et al. A One-Health approach to investigating an outbreak of alimentary tick-borne encephalitis in a non-endemic area in France (Ain, Eastern France): a longitudinal serological study in livestock, detection in ticks, and the first tick-borne encephalitis virus isolation and molecular characterisation. Front Microbiol. 2022;13:863725.  https://doi.org/10.3389/fmicb.2022.863725  PMID: 35479640 
  8. Michelitsch A, Wernike K, Klaus C, Dobler G, Beer M. Exploring the reservoir hosts of tick-borne encephalitis virus. Viruses. 2019;11(7):669.  https://doi.org/10.3390/v11070669  PMID: 31336624 
  9. Barrows NJ, Campos RK, Liao KC, Prasanth KR, Soto-Acosta R, Yeh SC, et al. Biochemistry and molecular biology of Flaviviruses. Chem Rev. 2018;118(8):4448-82.  https://doi.org/10.1021/acs.chemrev.7b00719  PMID: 29652486 
  10. European Centre for Disease Prevention and Control (ECDC). Factsheet about tick-borne encephalitis (TBE). Stockholm: ECDC. [Accessed: 8 Dec 2022]. Available from: https://www.ecdc.europa.eu/en/tick-borne-encephalitis/facts/factsheet
  11. Kaiser R. Langzeitprognose bei primär myelitischer Manifestation der FSME. Eine Verlaufsanalyse über 10 Jahre. [Long-term prognosis of patients with primary myelitic manifestation of tick-borne encephalitis: a trend analysis covering 10 years]. Nervenarzt. 2011;82(8):1020-5. German.  https://doi.org/10.1007/s00115-011-3254-2  PMID: 21424414 
  12. Bogovic P, Strle F. Tick-borne encephalitis: a review of epidemiology, clinical characteristics, and management. World J Clin Cases. 2015;3(5):430-41.  https://doi.org/10.12998/wjcc.v3.i5.430  PMID: 25984517 
  13. Kunze M, Banović P, Bogovič P, Briciu V, Čivljak R, Dobler G, et al. Recommendations to improve tick-borne encephalitis surveillance and vaccine uptake in Europe. Microorganisms. 2022;10(7):1283.  https://doi.org/10.3390/microorganisms10071283  PMID: 35889002 
  14. Andersson CR, Vene S, Insulander M, Lindquist L, Lundkvist A, Günther G. Vaccine failures after active immunisation against tick-borne encephalitis. Vaccine. 2010;28(16):2827-31.  https://doi.org/10.1016/j.vaccine.2010.02.001  PMID: 20167301 
  15. Hansson KE, Rosdahl A, Insulander M, Vene S, Lindquist L, Gredmark-Russ S, et al. Tick-borne encephalitis vaccine failures: a 10-year retrospective study supporting the rationale for adding an extra priming dose in individuals starting at age 50 years. Clin Infect Dis. 2020;70(2):245-51.  https://doi.org/10.1093/cid/ciz176  PMID: 30843030 
  16. Wondim MA, Czupryna P, Pancewicz S, Kruszewska E, Groth M, Moniuszko-Malinowska A. Epidemiological trends of trans-boundary tick-borne encephalitis in Europe, 2000-2019. Pathogens. 2022;11(6):704.  https://doi.org/10.3390/pathogens11060704  PMID: 35745558 
  17. Charrel RN, Attoui H, Butenko AM, Clegg JC, Deubel V, Frolova TV, et al. Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect. 2004;10(12):1040-55.  https://doi.org/10.1111/j.1469-0691.2004.01022.x  PMID: 15606630 
  18. Jaenson TGT, Hjertqvist M, Bergström T, Lundkvist A. Why is tick-borne encephalitis increasing? A review of the key factors causing the increasing incidence of human TBE in Sweden. Parasit Vectors. 2012;5(1):184.  https://doi.org/10.1186/1756-3305-5-184  PMID: 22937961 
  19. European Centre for Disease Prevention and Control (ECDC). Tick-borne encephalitis - Annual Epidemiological Report for 2020. Stockholm: ECDC; 28 Oct 2022. Available from: https://www.ecdc.europa.eu/en/publications-data/tick-borne-encephalitis-annual-epidemiological-report-2020
  20. Holding M, Dowall SD, Medlock JM, Carter DP, Pullan ST, Lewis J, et al. Tick-borne encephalitis virus, United Kingdom. Emerg Infect Dis. 2020;26(1):90-6.  https://doi.org/10.3201/eid2601.191085  PMID: 31661056 
  21. Stoefs A, Heyndrickx L, De Winter J, Coeckelbergh E, Willekens B, Alonso-Jiménez A, et al. Autochthonous cases of tick-borne encephalitis, Belgium, 2020. Emerg Infect Dis. 2021;27(8):2179-82.  https://doi.org/10.3201/eid2708.211175  PMID: 34111382 
  22. Public Health Agency of Sweden. Tick Borne Encephalitis (TBE) – sjukdomsstatistik. [Tick-borne encephalitis – disease statistics]. Stockholm: Public Health Agency of Sweden. [Accessed: 8 Dec 2022]. Swedish. Available from: https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistik-a-o/sjukdomsstatistik/tick-borne-encephalitis-tbe/
  23. Holmgren EB, Forsgren M. Epidemiology of tick-borne encephalitis in Sweden 1956-1989: a study of 1116 cases. Scand J Infect Dis. 1990;22(3):287-95.  https://doi.org/10.3109/00365549009027050  PMID: 2371544 
  24. Gustafson R, Forsgren M, Gardulf A, Granström M, Svenungsson B. Clinical manifestations and antibody prevalence of Lyme borreliosis and tick-borne encephalitis in Sweden: a study in five endemic areas close to Stockholm. Scand J Infect Dis. 1993;25(5):595-603.  https://doi.org/10.3109/00365549309008548  PMID: 8284644 
  25. Gustafson R, Svenungsson B, Gardulf A, Stiernstedt G, Forsgren M. Prevalence of tick-borne encephalitis and Lyme borreliosis in a defined Swedish population. Scand J Infect Dis. 1990;22(3):297-306.  https://doi.org/10.3109/00365549009027051  PMID: 2371545 
  26. Svensson J, Christiansen CB, Persson KEM. A serosurvey of tick-borne encephalitis virus in Sweden: different populations and geographical locations. Vector Borne Zoonotic Dis. 2021;21(8):614-9.  https://doi.org/10.1089/vbz.2020.2763  PMID: 34028305 
  27. Albinsson B, Vene S, Rombo L, Blomberg J, Lundkvist Å, Rönnberg B. Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017. Euro Surveill. 2018;23(3):17-00838.  https://doi.org/10.2807/1560-7917.ES.2018.23.3.17-00838  PMID: 29386094 
  28. Albinsson B, Rönnberg B, Vene S, Lundkvist Å. Antibody responses to tick-borne encephalitis virus non-structural protein 1 and whole virus antigen-a new tool in the assessment of suspected vaccine failure patients. Infect Ecol Epidemiol. 2019;9(1):1696132.  https://doi.org/10.1080/20008686.2019.1696132  PMID: 31839903 
  29. Mora-Cárdenas E, Aloise C, Faoro V, Knap Gašper N, Korva M, Caracciolo I, et al. Comparative specificity and sensitivity of NS1-based serological assays for the detection of flavivirus immune response. PLoS Negl Trop Dis. 2020;14(1):e0008039.  https://doi.org/10.1371/journal.pntd.0008039  PMID: 31995566 
  30. Stiasny K, Leitner A, Holzmann H, Heinz FX. Dynamics and extent of non-structural protein 1-antibody responses in tick-borne encephalitis vaccination breakthroughs and unvaccinated patients. Viruses. 2021;13(6):1007.  https://doi.org/10.3390/v13061007  PMID: 34072119 
  31. Salat J, Mikulasek K, Larralde O, Pokorna Formanova P, Chrdle A, Haviernik J, et al. Tick-borne encephalitis virus vaccines contain non-structural protein 1 antigen and may elicit NS1-specific antibody responses in vaccinated individuals. Vaccines (Basel). 2020;8(1):81.  https://doi.org/10.3390/vaccines8010081  PMID: 32059489 
  32. Salat J, Straková P, Ruzek D. Dynamics of whole virus and non-structural protein 1 (NS1) IgG response in mice immunised with two commercial tick-borne encephalitis vaccines. Vaccines (Basel). 2022;10(7):1001.  https://doi.org/10.3390/vaccines10071001  PMID: 35891164 
  33. Girl P, Bestehorn-Willmann M, Zange S, Borde JP, Dobler G, von Buttlar H. Tick-borne encephalitis virus nonstructural protein 1 IgG Enzyme-Linked Immunosorbent Assay for differentiating infection versus vaccination antibody responses. J Clin Microbiol. 2020;58(4):e01783-19.  https://doi.org/10.1128/JCM.01783-19  PMID: 31969423 
  34. R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2020. Available from: https://www.R-project.org
  35. Euringer K, Girl P, Kaier K, Peilstöcker J, Schmidt M, Müller-Steinhardt M, et al. Tick-borne encephalitis virus IgG antibody surveillance: vaccination- and infection-induced seroprevalences, south-western Germany, 2021. Euro Surveill. 2023;28(12):2200408.  https://doi.org/10.2807/1560-7917.ES.2023.28.12.2200408  PMID: 36951789 
  36. World Health Organization (WHO). Vaccines against tick-borne encephalitis: WHO position paper - 2011. Weekly Epidemiological Record, 2011, vol. 86, 24. Geneva: WHO; 10 Jun 2011. Available from: https://www.who.int/publications-detail-redirect/WHO-WER8624
  37. Pfizer AB. Stor ökning av TBE och färre vaccinerades 2021. [A large increase in TBE and fewer were vaccinated in 2021]. Stockholm: Pfizer AB; 7 Jun 2022. Swedish. Available from: https://www.pfizer.se/om-pfizer/aktuellt/artiklar/stor-okning-av-tbe-och-farre-vaccinerades-2021
  38. Jaenson TG, Jaenson DG, Eisen L, Petersson E, Lindgren E. Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden. Parasit Vectors. 2012;5(1):8.  https://doi.org/10.1186/1756-3305-5-8  PMID: 22233771 
  39. Ostfeld RS, Brunner JL. Climate change and Ixodes tick-borne diseases of humans. Philos Trans R Soc Lond B Biol Sci. 2015;370(1665):20140051.  https://doi.org/10.1098/rstb.2014.0051  PMID: 25688022 
  40. Lindgren E, Tälleklint L, Polfeldt T. Impact of climatic change on the northern latitude limit and population density of the disease-transmitting European tick Ixodes ricinus. Environ Health Perspect. 2000;108(2):119-23.  https://doi.org/10.1289/ehp.00108119  PMID: 10656851 
  41. Omazic A, Han S, Albihn A, Ullman K, Choklikitumnuey P, Perissinotto D, et al. Ixodid tick species found in northern Sweden - Data from a frontier area. Ticks Tick Borne Dis. 2023;14(6):102244.  https://doi.org/10.1016/j.ttbdis.2023.102244  PMID: 37611507 
  42. Blomqvist G, Näslund K, Svensson L, Beck C, Valarcher JF. Mapping geographical areas at risk for tick-borne encephalitis (TBE) by analysing bulk tank milk from Swedish dairy cattle herds for the presence of TBE virus-specific antibodies. Acta Vet Scand. 2021;63(1):16.  https://doi.org/10.1186/s13028-021-00580-4  PMID: 33827636 
  43. Atsma F, Veldhuizen I, Verbeek A, de Kort W, de Vegt F. Healthy donor effect: its magnitude in health research among blood donors. Transfusion. 2011;51(8):1820-8.  https://doi.org/10.1111/j.1537-2995.2010.03055.x  PMID: 21342203 
  44. Swedish Blood Alliance (SweBA). Blodverksamheten i Sverige. [Blood donations in Sweden]. Uppsala: SweBA; May 2019. Swedish. Available from: http://www.kitm.se/wp-content/uploads/2019/05/Blodverksamheten-i-Sverige-2018-1.2.pdf
Seroprevalence of tick-borne encephalitis virus and vaccination coverage of tick-borne encephalitis, Sweden, 2018 to 2019
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Bo+Albinsson&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Albinsson Bo</a>, <a href="/search?value1=Tove+Hoffman&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hoffman Tove</a>, <a href="/search?value1=Linda+Kolstad&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kolstad Linda</a>, <a href="/search?value1=Tomas+Bergstr%C3%B6m&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bergström Tomas</a>, <a href="/search?value1=Gordana+Bogdanovic&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bogdanovic Gordana</a>, <a href="/search?value1=Anna+Heydecke&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Heydecke Anna</a>, <a href="/search?value1=Mirja+H%C3%A4gg&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hägg Mirja</a>, <a href="/search?value1=Torbj%C3%B6rn+Kjerstadius&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kjerstadius Torbjörn</a>, <a href="/search?value1=Ylva+Lindroth&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lindroth Ylva</a>, <a href="/search?value1=Annika+Petersson&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Petersson Annika</a>, <a href="/search?value1=Marie+Stenberg&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Stenberg Marie</a>, <a href="/search?value1=Sirkka+Vene&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vene Sirkka</a>, <a href="/search?value1=Patrik+Ellstr%C3%B6m&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ellström Patrik</a>, <a href="/search?value1=Bengt+R%C3%B6nnberg&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Rönnberg Bengt</a>, <a href="/search?value1=%C3%85ke+Lundkvist&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lundkvist Åke</a></span>. Seroprevalence of tick-borne encephalitis virus and vaccination coverage of tick-borne encephalitis, Sweden, 2018 to 2019. <a href="/content/ecdc">Euro Surveill.</a> 2024;29(2):pii=2300221. <a href="https://doi.org/10.2807/1560-7917.ES.2024.29.2.2300221" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2024.29.2.2300221</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 14 Apr 2023;&nbsp;&nbsp; <span class="generated">Accepted</span>: 07 Nov 2023 </span> </p>
/content/10.2807/1560-7917.ES.2024.29.2.2300221
/content/10.2807/1560-7917.ES.2024.29.2.2300221
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error